Analysen von James Gordon
| 25.10.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 19.10.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 10.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 04.10.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 21.09.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 16.09.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.09.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.08.16 | GSK Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 10.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 09.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 08.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 02.08.16 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 29.07.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.07.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 13.07.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.07.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 07.06.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 19.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 28.04.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 25.04.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 21.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.03.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.03.16 | Sanofi Underweight | JP Morgan Chase & Co. | |
| 31.03.16 | Roche overweight | JP Morgan Chase & Co. | |
| 24.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.03.16 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 03.03.16 | MorphoSys Neutral | JP Morgan Chase & Co. | |
| 29.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 19.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 19.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 04.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.02.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 01.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 22.01.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.01.16 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.01.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 18.12.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 08.12.15 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 20.11.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.11.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.11.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 29.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.10.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 27.10.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 26.10.15 | GSK Neutral | JP Morgan Chase & Co. | |